Hatinh Pharmaceutical JSC

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000HDP1
VND
25,300.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.38

stock-summary
Return on Equity

9.84%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.2%
0%
1.2%
6 Months
1.2%
0%
1.2%
1 Year
26.5%
0%
26.5%
2 Years
63.23%
0%
63.23%
3 Years
83.33%
0%
83.33%
4 Years
57.14%
0%
57.14%
5 Years
0%
0%
0.0%

Hatinh Pharmaceutical JSC for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.70%
EBIT Growth (5y)
6.79%
EBIT to Interest (avg)
4.21
Debt to EBITDA (avg)
1.34
Net Debt to Equity (avg)
0.38
Sales to Capital Employed (avg)
2.42
Tax Ratio
20.48%
Dividend Payout Ratio
91.37%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.26%
ROE (avg)
9.10%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
2.33
EV to EBITDA
1.47
EV to Capital Employed
0.28
EV to Sales
0.12
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.78%
ROE (Latest)
9.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Hatinh Pharmaceutical JSC"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is 36.61% vs 5.06% in Dec 2021",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is 76.93% vs 31.17% in Dec 2021",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "473,580.80",
          "val2": "346,665.30",
          "chgp": "36.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "37,236.90",
          "val2": "30,071.10",
          "chgp": "23.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4,190.10",
          "val2": "4,033.20",
          "chgp": "3.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "164.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16,849.50",
          "val2": "9,523.50",
          "chgp": "76.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "54.60%",
          "val2": "46.70%",
          "chgp": "0.79%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'22stock-summary
Dec'22
Dec'21
Change(%)
Net Sales
473,580.80
346,665.30
36.61%
Operating Profit (PBDIT) excl Other Income
37,236.90
30,071.10
23.83%
Interest
4,190.10
4,033.20
3.89%
Exceptional Items
164.80
0.00
Consolidate Net Profit
16,849.50
9,523.50
76.93%
Operating Profit Margin (Excl OI)
54.60%
46.70%
0.79%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2022 is 36.61% vs 5.06% in Dec 2021

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2022 is 76.93% vs 31.17% in Dec 2021

stock-summaryCompany CV
About Hatinh Pharmaceutical JSC stock-summary
stock-summary
Hatinh Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Hatinh Pharmaceutical Joint Stock Company (Hadiphar) is a Vietnam-based company primarily engaged in pharmaceuticals sector. The Company's leading business activities include the manufacture and distribution of diversified medicinal products, such as antibiotics, pain killers, anti-inflammatory and anti-allergy drugs, topical cream, nervine tonics, vitamins, Chinese medicine and functional food, among others. Hadiphar is also involved in the production of medicinal materials and the wholesale of pharmaceuticals.
Company Coordinates stock-summary
Company Details
So 167 duong Ha Huy Tap, phuong Nam Ha , HA TINH None : None
stock-summary
Tel: 84 23 93892549
stock-summary
Registrar Details